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Chapter 3.3
DRUG USE AMONG MEN 
WHO HAVE SEX WITH MEN
Implications for harm 
reduction
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Introduction
Numerous studies have demonstrated that men who have 
sex with men (MSM) experience disproportionate levels of 
ill-health1-3 compared to the general population, and are one 
of the highest risk groups for HIV in every part of the world.4, 
5 MSM frequently face significant stigma and discrimination 
from their families, communities and, in some countries, 
are the subject of systemic repression and persecution.7 
Often this repression and stigmatisation can make accessing 
appropriate health services, where they exist, problematic.8, 9 
A significant concern among health professionals and 
advocates who work to improve the health and well-being 
of MSM relates to the prevalence of drug use within the 
population, its uses and its associated harms. The chapter 
begins with an overview of the range of drugs taken by MSM, 
followed by a description of prevalence across the world 
(where such data exist) and a discussion of data quality. It then 
assesses the reasons for drug use by MSM and the harms that 
may be associated with such use. The final section highlights 
interventions to help reduce the harms associated with drug 
use among MSM. 
MSM, gay, homosexual, queer?
Terminology to describe men who are attracted to, or 
have sex with, other men is often carefully selected. 
Some men who are attracted to, or have sex with, other 
men may describe themselves as ‘gay’, while others do 
not. Some might use the term ‘homosexual’ (literally 
meaning they have a sexual orientation towards people 
of the same sex) or ‘queer’ (referring to a sexuality that 
deviates from the ‘norm’). ‘Men who have sex with men’ 
(MSM) refers only to the act of sexual contact between 
two men and is rarely used by men themselves to 
describe their sexuality. Health professionals often use 
the term MSM because it relates to behaviour which, 
when considering issues such as HIV, other sexually 
transmitted infections (STIs) or drug use, is more 
important than the identity an individual might assign 
themselves. When working with this population it is 
important that you establish the term with which male 
clients or service users are most comfortable. 
The range of drug use among MSM 
Studies indicate that MSM utilise a broad range of drugs. 
This chapter relates only to non-prescription drugs that 
are considered illegal or otherwise ‘recreational’ in most 
countries. The following is a list of drugs known to be 
used by MSM, and includes street names or regional 
variations.a 
 » Amphetamine (speed, uppers, sulphate, whizz) 
 » Cannabis (marijuana, Mary Jane, dope, pot, spliff, 
hash(ish), weed, puff, grass, herb, draw, wacky 
backy, ganja, hemp)
 » Cocaine (coke, Charlie, C, snow, blow, a toot, 
Bolivian/Peruvian/Colombian marching powder)
 » Crack cocaine (rock, base) – essentially a super-
strength cocaine
 » Crystal methamphetamine (Crystal, Tina, meth, ice, 
crank) – essentially a super-strength amphetamine
 » Ecstasy (E, MDMA, X, XTC) 
 » GHB/GBL (Gina, G, liquid ecstasy) 
 » Heroin (smack, skag, junk, horse)
 » Ketamine (K, special K, vitamin K)
 » LSD (acid, a trip)
 » Mephadrone (MCAT, Meow-meow)
 » Poppers (amyl, butyl, isobutyl nitrate, aromas, liquid 
incense) – the formula frequently changes, but they 
are chemicals from the alkyl nitrite family.
a
Prevalence of drug use among MSM
Establishing the prevalence of drug use among MSM in 
different parts of the world is challenging. In a large number 
of countries, homosexuality, or sex between men, is illegal, 
making the collection of data relating to sexuality challenging 
and complex. Even where research about MSM and drug 
use has been conducted, it is often difficult, or impossible, 
to compare because of inconsistent methodologies, such as 
different recruitment methods, a focus on different drugs or 
use in different settings or across varying time frames (e.g. 
within the last month, the last three months, within the past 
12 months or drug use ever in life). In addition, the use of 
drugs may vary wildly not only from one region of the world 
to another but from one country to the next, between cities 
in the same country or even among different venues within 
the same city. As is the case with other populations, drug use 
among MSM in various areas can change significantly within 
short spaces of time, meaning that data collected can quickly 
become redundant.
The literature review that follows is written with the best data 
publicly available in English. 
a    For a detailed account of these drugs commonly used by MSM and their effects, see 
http://www.drugfucked.tht.org.uk/. 
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Africa
There has been relatively little research in general conducted 
with MSM in African nations, and only a small number of 
studies that have specifically explored drug use. Much of the 
research that has been conducted relates solely to injecting 
drug use (IDU), with rates among MSM ranging from 3.4 to 12% 
in Malawi and 8% in Namibia,10 all within the last six months, 
and 14% within the last year among MSM in Zanzibar.11 Drug 
use among MSM in South Africa has received more attention 
than in other countries, with one study reporting that 11% of 
men described having sex while under the influence of drugs 
within the previous 12 months,12 and further mixed-method 
research suggesting significant regional variation in drug use 
across different cities in the country.13, 14 For example, crystal 
methamphetamine was the most commonly used drug 
among MSM in Cape Town, but dipipanone hydrochloride was 
more common in Durban. 
Asia
The 2010 Asian MSM Internet Sex Survey15 included 10,861 
respondents recruited online from China, Singapore, 
Malaysia, Taiwan, Hong Kong, Thailand, Japan, Indonesia, the 
Philippines, Korea and Vietnam. Table 1 displays the levels of 
reported drug use within the past six months (findings are 
not publicly available at country level). Data from this survey 
also indicate that drug use was significantly higher among 
MSM with diagnosed HIV, particularly with respect to crystal 
methamphetamine, ketamine and ecstasy. A 2009 study in 
Thailand identified an association between HIV prevalence 
and a history of drug use.16
Table 1: Levels of drug use among respondents in the Asian 
MSM Internet Sex Survey
Stimulant drugs % Use in last 6 months
Crystal meth 4.0
Ecstasy 8.1
Cocaine 1.8
Poppers 6.1
Cannabis 3.6
GHB 2.3
Ketamine 5.3
Several other studies across the continent have explored 
lifetime usage of drugs, with levels ranging from 6% in 
Vietnam17 and 11.7% in Taiwan18 to nearly 65% in Japan19 
(although much of this variation can be accounted for by 
differences in sampling and recruitment).
Levels of IDU among MSM in Asia have generally been low.17, 
20, 21 There are currently no data publically available on the 
prevalence of drug use among MSM living in Central Asian 
Republics. 
Australasia
Frequent gay community surveys in Australia and New 
Zealand provide a detailed picture of drug use among MSM in 
these countries, as displayed in table 2. 
In Australia, the proportion of men reporting any IDU in 
the previous six months has remained stable at around 
5–6% for the last ten years.26 While the percentage of men 
using poppers has fallen slightly over the last nine years, 
still in 2009 an average of 31.8% of MSM across the country 
reported use within the previous six months. The Australian 
surveys typically identify higher rates of all drug use in Sydney 
compared to other parts of the country.
Table 2: Prevalence of drug use among MSM in Australasia within the previous 6 months
Cocaine % Poppers % Cannabis % Ecstasy % Methamphetamine % Ketamine % Source
Australia 
(Sydney)
20.6 40.4 27.9 29.8 11.1 9.6
2011 Gay Community Periodic 
Survey Sydney22 
Australia 
(Melbourne)
12.4 35.4 27.6 21.5 8.9 6.0
2011 Gay Community Periodic 
Survey Melbourne23 
Australia 
(Adelaide)
7.1 21.9 34.6 17.2 9.5 2.1
2011 Gay Community Periodic 
Survey Adelaide24 
New Zealand 
(Auckland)
7.3 40 37.5 21.2 7.9 5.7
2006 Gay Auckland Periodic 
Sex Survey25
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Caribbean
Prevalence data for drug use among MSM in the Caribbean 
is extremely scarce. Secondary analysis of a representative 
general household survey data collected in Puerto Rico27 
reported lifetime use of cannabis (63.4%), amphetamines 
(20%) and heroin (20%). A quarter of MSM reported using 
cannabis (24.4%) and cocaine (24.4%) in the past 12 months.
The UNAIDS-sponsored Caribbean Men for Men Internet Sex 
Survey (CARIMIS) is underway at the time of writing and will 
report its findings in the summer of 2012. This survey will 
provide drug use data for each of the Caribbean nations and 
territories and will be a useful source of information for the 
development of future interventions.b 
b    See  http://www.carimis.org
Europe
Comprehensive data on drug use among MSM was collected as 
part of the European Man for Man Internet Sex Survey (EMIS). 
This online survey was open for completion in 25 languages 
in the summer of 2010 and recruited a total of 181,495 men. 
It asked questions about use of a range of drugs within the 
previous 4 weeks (as displayed in table 3). While country-level 
data will become available in the near future, at present EMIS 
data are reported on a European sub-regional level. 
Research in the UK29 that explored drug use levels among 
MSM within the previous 12 months reported levels ranging 
from 39.4% for poppers, 27.7% for cannabis, 18.5% for ecstasy 
and 4.7% for methamphetamine (with significant regional 
variations evident and highest usage in London.)30 Drug 
use among MSM in Catalonia, Spain, within the previous 12 
months followed a broadly similar pattern (poppers 40.8%; 
cannabis 26.0%; ecstasy 10.2% and methamphetamine 
3.0%.)31 
Table 3: Use of drugs among MSM across Europe within the previous four weeks
Region of residence
poppers use in last 4 
weeks
cannabis (or LSD) use in 
last 4 weeks
Heroin/crack use in last 
4 weeks
party drugs* use in last 
4 weeks
West: Belgium, France, Rep. 
of Ireland, the Netherlands, 
the UK
28.3 13.8 0.4 10.6
North West: Denmark, 
Finland, Norway, Sweden
13.8 6.2 0.3 3.1
Central-West: Austria, 
Switzerland, Germany, 
Luxembourg
22.0 10.1 0.2 4.9
South West: Greece, Spain, 
Italy, Portugal
10.9 13.6 0.4 6.6
North East: Estonia, 
Lithuania, Latvia
6.2 4.9 0.2 2.3
Central-East: Czech 
Republic, Hungary, Poland, 
Slovenia, Slovakia 
15.2 10.2 0.3 4.9
South East (EU): Bulgaria, 
Cyprus, Malta, Romania
7.9 5.9 0.3 3.0
South East (non-EU): 
Bosnia & Herzegovina, 
Croatia, Macedonia, Serbia, 
Turkey
7.7 8.6 0.4 2.5
East: Belarus, Moldova, 
Russia, Ukraine
8.3 5.2 0.3 2.4
* Party drugs include ecstasy, amphetamine, methamphetamines, mephadrone, GHB, ketamine and cocaine. Adapted from EMIS 
Network.28
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North America
There are no publically available national MSM drug use 
prevalence data for the USA: prevalence is reported only at 
a city or state level. This approach is appropriate in terms of 
influencing local harm reduction interventions but makes 
country-level comparison difficult. Table 4 provides a snapshot 
of drug use prevalence in different cities, established via 
multiple surveys. 
Similar levels of poppers use among MSM have been observed 
in Canada.35 
A significant body of research has addressed 
methamphetamine use among MSM in the USA. This drug 
is commonly associated with euphoria, decreased sexual 
inhibition and hypersexual behaviour.36, 37 Analysis of data 
collected annually between 1996 and 2007 in Los Angeles 
found levels of methamphetamine use within the last 12 
months varying from 11% to 53%.38 A longitudinal study of 
club drug using gay and bisexual men in New York found that 
64.6% of their sample reported using methamphetamine 
within the previous four months.39 
Levels of IDU among MSM in both Canada and the USA have 
typically been very low.2, 40, 41, 42 
South America
Between 1999 and 2002 a series of 19 sero-epidemiological 
cross-sectional surveys43 were conducted among MSM in 
seven different South American nations: Argentina, Bolivia, 
Colombia, Ecuador, Paraguay, Peru and Uruguay. These 
surveys asked about history of drug use (ever) and analysed 
such usage in light of national HIV prevalence to identify 
significant associations. The surveys recruited a total of 13,847 
MSM participants by opportunistic, community sampling, 
although the number of participants varied considerably 
between countries. Reported data from Peru appear 
incomplete; therefore, Peru is not included in Table 5.
Table 4: Prevalence of drug use among MSM across the USA
City/region 
(Year of data 
collection)
Methamphetamine 
%
Cannabis 
%
Ecstasy 
%
Cocaine 
%
Poppers 
%
Study type
Time 
frame of 
drug use
Reference
New York 
(2007)
6.2 27.9 8.38 12.03 24.46
Community survey of 
MSM (n=740)
Within 
the last 3 
months
Carpiano et 
al. (2011)32
Chicago  
(2002–2003)
6 28 13 12 -
Household survey. Data 
from HIV-negative MSM 
(n=151)
Within 
the last 6 
months
Fendrich et 
al. (2010)33
San Francisco 
(1999–2001)
23* - - 19 37
Randomised behavioural 
intervention of MSM 
accessing counselling 
(n=736)
Lifetime 
use
Colfax et al. 
(2005)34
* Includes speed and any form of methamphetamine
Table 5: Reported drug use (ever) among MSM from six South American countries
Drug used (ever) Colombia % Ecuador % Bolivia % Argentina % Uruguay % Paraguay %
Cannabis 31.2 17.4 21.4 15.4 14.8 42.4
Heroin 2.4 0.6 0.0 0.4 0.2 4.3
Cocaine 14 4.9 17.2 6.7 21.9 26.4
[Adapted from Bautista et al.]43
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Broad patterns of drug use among all 
MSM
In reviewing this broad literature from across the globe, 
several patterns in MSM drug use emerge. Firstly, most 
drug use among MSM appears to be episodic, with weekly 
or monthly use far higher than daily.15, 29, 44 This might 
suggest that most MSM who report drug use are not drug-
dependent but instead use drugs for specific purposes (such 
as when partying, socialising or when seeking or having sex).45 
Episodic drug use may also reflect specific periods of stress or 
uncertainty, such as an HIV diagnosis, struggles in the process 
of ‘coming out’, or may occur in combination with periods of 
depression or anxiety. 
Secondly, MSM, or gay men, are not a homogenous group in 
terms of drug use. Prevalence of use was very often higher 
among further marginalised or minority groups, such as ethnic 
minority gay men in the USA,46-48 and is often higher among 
younger men.42, 49, 50 Use of most drugs (except cannabis) 
tends to be higher among MSM living in large urban centres, 
particularly those with large gay populations such as Berlin, 
Sydney, London and San Francisco than it is among men in 
more rural areas.26, 30 
Thirdly, polydrug use (taking more than one drug during the 
same session or within a fixed time frame) is common among 
MSM, particularly with regards to stimulants (‘party drugs’) 
such as ecstasy, cocaine, amphetamines or ketamine.34, 51 
Fourthly, across the world, the prevalence of IDU, especially 
heroin, was generally very low. Other than in South Africa, 
reported levels of IDU in non-purposive samples rarely 
exceeded 5%. Previous authors52 have suggested that the 
reason insufficient attention has been paid to drug use 
among MSM is specifically because levels of heroin use – 
often the focus of drug harm reduction services – have been 
comparatively low. In the absence of heroin-related health 
concerns, and those social or community harms such as crime 
which are often associated with problematic heroin use, the 
harm reduction needs of gay men have not always featured 
on the radar of policymakers. 
Harms associated with drug use 
among MSM
Harms to physical and mental health
The physical and mental health harms associated with 
cocaine, heroin, ecstasy, cannabis, LSD and amphetamines are 
well documented, and are likely to be similarly represented in 
MSM. 
Crystal methamphetamine is a super-strength amphetamine 
stimulant, which results in high-energy feelings of confidence, 
invincibility or impulsiveness. Continuous stimulation of the 
nervous system by crystal methamphetamine has been 
known to cause anxiety, depression, confusion, insomnia, 
psychosis and suicidal ideation,53 and long-term use may also 
result in a loss of motor control or memory.54
GHB/GBL (Gamma-butyrolactone) is a party drug that brings a 
sense of euphoria. It is usually sold diluted in water, although 
just an extra millilitre of GBL over a moderate dose can result in 
an overdose, the effects of which are often unconsciousness, 
coma or death by respiratory depression. GBL can be addictive 
(although this usually only develops over longer periods 
of time) and, therefore, can result in significant withdrawal 
effects. 
After-effects of inhaling poppers can include headaches, skin 
rashes, sinus pains and burns, but only if the liquid comes 
into contact with the skin. They have also been known to 
cause nausea and vomiting. Inhaling poppers after taking 
anti-impotence drugs, such as Viagra or Cialis, can result in a 
dangerous drop in blood pressure.55 This may be more likely 
to occur if also taking a protease inhibitor as part of HIV anti-
retroviral therapy (ART). 
There is evidence to suggest that the use of a range of drugs, 
particularly methamphetamines, GBL and ecstasy, might have 
a detrimental impact on adherence to ART.56, 57
Harms to sexual health and well-being
The association between drug use (particularly 
methamphetamine, ecstasy and cocaine) and sexual risk 
behaviours is complex, and a comprehensive analysis of this 
literature is beyond the scope of this chapter (for a review, 
see Corsi et al.58 or Romanelli et al.59). It is possible to say that 
there is a clear association between certain drug use and sex 
that carries a risk of HIV transmission. However, it is not clear 
whether this is causal or simply co-relational. 
Significant attention has been paid to the role of 
methamphetamine in HIV transmission risk behaviours, 
particularly in the USA. This drug can cause feelings of 
hypersexualisation and is commonly utilised as part of 
sexual marathons (protracted periods of sexual activity) 
and group sex activities.60-62 Ensuing rectal trauma facilitates 
the transmission of HIV. Numerous studies have suggested 
that the use of methamphetamine causes high-risk sexual 
behaviour,63-65 perhaps via a myopic mechanism or the 
removal of sexual inhibitions. However, other studies have 
challenged this causal pathway.66, 67
Other associations with high-risk sexual behaviour have been 
identified in relation to ecstasy,68 GHB/GBL69 and ketamine.70 
Men who reported polydrug use in the recent past (up to 
three months) are more likely to report HIV risk behaviours 
than men who took only one drug.44, 47 
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Poppers cause blood vessels to dilate and also relax the 
anal sphincter muscle. This can make receptive anal 
intercourse more comfortable for some men. The process of 
vasodilatation, and the fact that sex may be rougher or last for 
longer while using poppers, means that their use during sero-
discordant anal intercourse can increase the probability of HIV 
transmission by a factor of three.71, 72 
Motivations for drug use
There has been relatively little research exploring the reasons 
or motivations for drug use among MSM or the personal and 
social context within which drug use occurs, particularly 
outside North America, Western Europe and Australia. 
Numerous authors52, 73 have highlighted that in most settings 
the majority of venues to meet other men for social and/
or sexual interaction are those where alcohol is served and 
drug use is common. Clubs and bars are the centre of most 
‘gay scenes’, and drug use itself is normalised within this 
environment. Drugs often serve a very deliberate purpose 
in helping individuals to relax, to socialise, to mitigate social 
unease and to gain confidence in seeking sexual partners.74 
The value of these actions and activities should not be 
underestimated by those seeking to support MSM to reduce 
any harm that may be associated with their drug use.
Further to this, a significant body of research indicates that 
(crystal) methamphetamines are often used by MSM to 
psychologically enhance sexual experience, to maintain 
sexual activity over long periods of time and to facilitate 
sexual desires by dissipating sexual inhibitions.75-77 Drugs may 
also help MSM with diagnosed HIV, in particular, to ‘cognitively 
escape’ from fear of rejection and negative self-perception 
and to cope with broader emotional and physical demands of 
living with HIV on a daily basis.78
The best indicator of whether drug use is problematic, or 
is in danger of becoming so, is if the individual concerned 
considers their use in this way. As already discussed, drug use 
among MSM in general tends to be episodic in nature, but 
dependency can still develop and significant harm can result. 
For many men, drug use becomes problematic when the costs 
or side-effects associated with usage impinge on their ability 
to live the life they are comfortable or content with.
Harm reduction interventions to meet 
the needs of MSM
Drug use interventions for MSM need to empower men with 
honest information about what the possible effects (both 
positive and negative) might be of taking a range of drugs. 
They should seek to support men, and those around them, 
to control or limit their use, or to limit the harms associated 
with such use, at times when they consider their drug 
use is causing harm to themselves or others. This can be 
accomplished in a number of ways, ranging from provision 
of educational information to psychotherapeutic support 
and pharmacological interventions. Whatever the setting, 
interventions should take into account each man’s personal 
circumstances, acknowledging that drugs can serve a useful 
purpose in their lives, particularly in terms of mitigating 
psychological unease or by facilitating social or sexual 
contact. Health professionals should take account of these 
motivations and work with men to identify what level or type 
of drug use they are comfortable with, and help to reduce 
harms associated with this use.
Numerous civil society organisations in Australia, Canada, 
Germany, Poland, the UK and USA have developed websites or 
printed information booklets that explain the effects of drugs 
commonly used by MSM, and describe ways in which any 
associated harms might be mitigated. They often also include 
information about the legal status of each drug, and provide 
referral information for direct contact services if readers 
consider their use problematic. 
Provision of psycho-therapeutic services or counselling 
specifically designed to address problematic drug use 
among MSM varies considerably across the world and 
within individual countries. They are known to currently 
exist in Australia, Canada, Germany, New Zealand, Norway, 
South Africa,79 Spain, Sweden, the UK and USA. A service 
in Hong Kong ran between 2007 and 2009. Such therapy 
includes drop-in advice, motivational interviewing, support 
groups and cognitive behavioural therapy. Many of these 
interventions appear grounded in evidence from evaluations 
of the general population (for review, see Shearer80), although 
there have been a number of evaluations of behaviour change 
interventions related to methamphetamine use specifically 
among MSM.81-83 In many instances, such evaluated 
programmes focus on reducing harms to sexual health and 
the likelihood of contracting or transmitting HIV, with mixed 
success (for review, see Rajasingham et al.57). In a very small 
number of settings, primarily the UK and USA, pharmacologic 
interventions exist to address methamphetamine use, but 
their effectiveness is still uncertain.84, 85
In Australia, and in many parts of Europe and North America, 
harm reduction services are situated within the HIV prevention 
sector, largely because of the association with sexual risk 
behaviours and because this sector is well established with 
strong links to the gay communities they serve. There is 
currently no provision of any harm reduction interventions 
specifically targeting MSM in Africa (except the Republic of 
South Africa), Asia, the Caribbean or South America. While 
MSM could access services for the general population (where 
they exist), previous research has reported that they often 
feel uncomfortable or unwelcome in such environments.52 
Drug use among MSM is frequently associated with ‘gay scene’ 
social activity or with sex, and many services for the general 
population may not be sufficiently knowledgeable, skilled or, 
indeed, accepting to help address drug use that occurs within 
these contexts. 
Chapter 3.3
154
Case study: 
antidote @ London friend
This organisation works exclusively with lesbian, gay, 
bisexual and transgender (LGBT) people who use drugs, 
the majority being gay men in their 20 and 30s, mostly 
employed and financially self-supporting. In the past 
three to four years the drug use profile of their clients 
has shifted towards crystal meth and GHB/GBL, with 
many people using them in sexual contexts. There 
has been a trend to inject crystal, and for GBL use to 
rapidly escalate to dependence levels (dosing around 
every two hours), so the type of intervention has had to 
extend to medical (mainly prescribing for GBL detox), 
having been mainly psychosocial. This typically involves 
administering benzodiazepines in high doses (often 
> 100mg/24hrs),6 which they offer in partnership with 
the NHS Club Drug Clinic, to help clients deal with 
withdrawal symptoms. Dependence on GBL is an entirely 
new phenomenon for members of the community, who 
have used other drugs, often without major problems, 
for many years.
Most service users do not fit the typical profile of 
mainstream UK drug services or the typical drug 
patterns presenting there. By offering a targeted service 
they are able to remove many of the barriers of users not 
identifying with generic support. Being an LGBT service 
means that people feel less judged and more able to talk 
about their full range of associated problems, which they 
may feel inhibited to do in generic services, particularly 
as it may involve talking about sexual behaviours they 
feel ashamed of. 
They work around reasons for using, dealing with 
cravings and trigger situations, negotiating safer 
boundaries and improving well-being overall; these are 
all typical substance misuse interventions, but it is their 
provision in a safe and understanding LGBT environment 
which sets the service apart. c 
c
Conclusions
This review has highlighted the extent of drug use among 
MSM and summarised the range of harms that can be 
associated with their use. Drug use is common among MSM 
and is well established in gay social and sexual environments. 
Given the significant harms associated with many of the drugs 
that MSM use, harm reduction interventions that meet the 
specific needs of MSM should be prioritised in all parts of the 
world.
 
c    See http://www.londonfriend.org.uk
Establishing the prevalence of drug use among MSM living 
in Central Asian Republics, South America, the Caribbean 
and Africa is a research priority. Systematic population and 
local-level estimations for MSM populations are a necessary 
precursor to this. There is a need for more qualitative research 
in many parts of the world that explores the reasons why MSM 
use drugs and the personal and social context of this use. 
Harm reduction practitioners should seek to understand 
variations in drug use among MSM in their local area and 
tailor interventions accordingly. They should attend to 
changes in such use over time, and be accepting of the social 
and sexual environments in which drug use often occurs. 
Harm reduction practitioners should also attend to ethnic or 
sexuality variation within MSM communities, acknowledging 
that further marginalised sections of the population are more 
likely to use drugs and for such use to be problematic. As the 
evidence base for prevalence, motivations, context and harms 
associated with drug use among MSM evolves, so it would be 
beneficial to develop toolkits for effective interventions for 
rollout in various settings. 
As long as homosexuality – or acts of sex between men – is 
criminalised, and as long as MSM face stigma and persecution, 
it will remain a significant challenge to develop and deliver 
effective interventions to meet the complex needs that this 
review identifies. Legal and policy reforms relating to MSM are 
required in a large number of countries if prevention of HIV 
transmission and a reduction in other harms associated with 
drug use is to be realised. 
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